SKYSTAR BIO-PHARMACEUTICAL CO Research and Development Expense
SKYSTAR BIO-PHARMACEUTICAL CO reported Research and Development Expense of $378.49 thousand for the 3-month period ending 2014-09-30, per its 10-Q filed 2014-11-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2014-11-14
- SKYSTAR BIO-PHARMACEUTICAL CO research and development expense for the quarter ending 2014-09-30 was $378.49K, a 16.69% increase year-over-year.
- SKYSTAR BIO-PHARMACEUTICAL CO research and development expense for the quarter ending 2014-06-30 was $798.98K, a 759.80% increase year-over-year.
- SKYSTAR BIO-PHARMACEUTICAL CO research and development expense for the quarter ending 2014-03-31 was $4.21K, a 813.88% increase year-over-year.
- SKYSTAR BIO-PHARMACEUTICAL CO research and development expense for the quarter ending 2013-12-31 was $538.29K, a 66.80% decline year-over-year.
- SKYSTAR BIO-PHARMACEUTICAL CO research and development expense for fiscal 2013 was $956.03K, a 55.62% decline from fiscal 2012.
- SKYSTAR BIO-PHARMACEUTICAL CO research and development expense for fiscal 2012 was $2.15M, a 23.45% decline from fiscal 2011.
- SKYSTAR BIO-PHARMACEUTICAL CO research and development expense for fiscal 2011 was $2.81M, a 310.98% increase from fiscal 2010.
- SKYSTAR BIO-PHARMACEUTICAL CO research and development expense for fiscal 2010 was $684.78K.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2014-09-30 | $378.49K 10-Q · filed 2014-11-14 | $1.18M derived: sum of 2 quarters · filed 2014-11-14 | $1.18M 10-Q · filed 2014-11-14 | $1.72M derived: sum of 4 quarters · filed 2014-11-14 |
| 2014-06-30 | $798.98K 10-Q · filed 2014-08-14 | $803.19K 10-Q · filed 2014-08-14 | $1.34M derived: sum of 3 quarters · filed 2014-08-14 | $1.67M derived: sum of 4 quarters · filed 2014-11-14 |
| 2014-03-31 | $4.21K 10-Q · filed 2014-05-15 | $542.50K derived: sum of 2 quarters · filed 2014-05-15 | $866.85K derived: sum of 3 quarters · filed 2014-11-14 | $959.78K derived: sum of 4 quarters · filed 2014-11-14 |
| 2013-12-31 | $538.29K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $862.64K derived: sum of 2 quarters · filed 2014-11-14 | $955.57K derived: sum of 3 quarters · filed 2014-11-14 | $956.03K 10-K · filed 2014-03-31 |
| 2013-09-30 | $324.35K 10-Q · filed 2014-11-14 | $417.28K derived: sum of 2 quarters · filed 2014-11-14 | $417.74K 10-Q · filed 2014-11-14 | $2.04M derived: sum of 4 quarters · filed 2014-11-14 |
| 2013-06-30 | $92.93K 10-Q · filed 2014-08-14 | $93.39K 10-Q · filed 2014-08-14 | $1.71M derived: sum of 3 quarters · filed 2014-08-14 | $1.91M derived: sum of 4 quarters · filed 2014-08-14 |
| 2013-03-31 | $461.00 10-Q · filed 2014-05-15 | $1.62M derived: sum of 2 quarters · filed 2014-05-15 | $1.82M derived: sum of 3 quarters · filed 2014-05-15 | $2.15M derived: sum of 4 quarters · filed 2014-05-15 |
| 2012-12-31 | $1.62M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $1.82M derived: sum of 2 quarters · filed 2014-03-31 | $2.15M derived: sum of 3 quarters · filed 2014-03-31 | $2.15M 10-K · filed 2014-03-31 |
| 2012-09-30 | $198.84K 10-Q · filed 2013-11-14 | $529.37K derived: sum of 2 quarters · filed 2013-11-14 | $533.02K 10-Q · filed 2013-11-14 | $1.17M derived: sum of 4 quarters · filed 2013-11-14 |
| 2012-06-30 | $330.53K 10-Q · filed 2013-08-14 | $334.19K 10-Q · filed 2013-08-14 | $968.37K derived: sum of 3 quarters · filed 2013-08-14 | $1.06M derived: sum of 4 quarters · filed 2013-08-14 |
| 2012-03-31 | $3.65K 10-Q · filed 2013-05-15 | $637.84K derived: sum of 2 quarters · filed 2013-05-15 | $728.96K derived: sum of 3 quarters · filed 2013-05-15 | $2.53M derived: sum of 4 quarters · filed 2013-05-15 |
| 2011-12-31 | $634.18K derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-01 | $725.30K derived: sum of 2 quarters · filed 2013-04-01 | $2.53M derived: sum of 3 quarters · filed 2013-04-01 | $2.81M 10-K · filed 2013-04-01 |
| 2011-09-30 | $91.12K 10-Q · filed 2012-11-14 | $1.89M derived: sum of 2 quarters · filed 2012-11-14 | $2.18M 10-Q · filed 2012-11-14 | $2.42M derived: sum of 4 quarters · filed 2012-11-14 |
| 2011-06-30 | $1.80M 10-Q/A · filed 2012-09-13 | $2.09M 10-Q/A · filed 2012-09-13 | $2.33M derived: sum of 3 quarters · filed 2012-09-13 | $2.54M derived: sum of 4 quarters · filed 2012-09-13 |
| 2011-03-31 | $287.47K 10-Q · filed 2012-05-15 | $527.97K derived: sum of 2 quarters · filed 2012-05-15 | $736.17K derived: sum of 3 quarters · filed 2012-05-15 | $928.25K derived: sum of 4 quarters · filed 2012-05-15 |
| 2010-12-31 | $240.50K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | $448.69K derived: sum of 2 quarters · filed 2012-03-30 | $640.78K derived: sum of 3 quarters · filed 2012-03-30 | $684.78K 10-K · filed 2012-03-30 |
| 2010-09-30 | $208.20K 10-Q · filed 2011-11-14 | $400.29K derived: sum of 2 quarters · filed 2011-11-14 | $444.28K 10-Q · filed 2011-11-14 | |
| 2010-06-30 | $192.09K 10-Q/A · filed 2011-09-21 | $236.08K 10-Q/A · filed 2011-09-21 |